Ethylenediaminetetraacetic acid or EDTA (Fisher Scientific, Cat number: O2783)
Dithiothreitol or DTT (Fisher Scientific, Cat number: BP-172)
Maltose (Fisher Scientific, Cat number: M75)
HEPES (Millipore Sigma, Cat number: H3375)
Buffer A (See Recipes)
Buffer B (see Recipes)
Buffer C (see Recipes)
Buffer D (see Recipes)
Buffer E (see Recipes)
Buffer F (see Recipes)
Equipment
Water Bath (Revolutionary Science)
Shaker incubator (Sanyo, orbital incubator)
Cell density meter (Ultrospec10 from GE healthcare)
Nanodrop 2000C (Thermo scientific)
High speed centrifuge (Beckman Coulter)
Emulsifex-C3 High pressure homogenizer
Benchtop centrifuge (Fisher Scientific)
NGC chromatography system (Biorad)
Procedure
Cloning in pMAL-c5e vector:
Restriction digestion of pUC57-EP300-KIX87 with Nde1 and Bam H1 restriction enzymes.
Restriction digestion of pMAL-c5e vector with Nde1 and BamH1 restriction enzymes.
1% agarose gel electrophoresis to separate the digested products.
Extract the digested products (EP300KIX87 and pMAL-c5e) from agarose gel using gel extraction Kit.
Ligation reaction for vector (pMAL-c5e) and insert (p300-KIX87) using quick ligase kit.
Transformed the ligated product into E. coli (NEB turbo) cells followed by colony picking on next day into 10 mL of TB media containing 100 mg/mL ampicillin.
Grow the cells at 37 °C for overnight at 260 rpm.
Plasmids isolation from colonies on transformed plate and sent for sequencing (Eurofin genomics).
Human EP300-KIX87 domain Protein sequence encoded by either ORF
MKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSNNNNNNNNNNLGDDDDKVPHMGIRKQWHEDITQDLRNHLVHKLVQAIFPTPDPAALKDRRMENLVAYARKVEGDMYESANNRAEYYHLLAEKIYKIQKELEEKRRTRL*Blue highlighted amino acids are from vector containing MBP tag.
(2) In the synthesized human EP300-KIX87 ORF, codon usage is optimized for E. coli expression. NdeI and BamH1restriction sites are used for open reading frame (ORF) ligation into a pMAL-c5e vector (ampicillin-resistant).
Overexpression of EP300-KIX87:
Transform E. coli Rosetta2 (DE3) cells with pMAL-c5e vector containing the human EP300-KIX87 domain open reading frame (residues 565-652).
Thaw one vial of competent cells on ice per transformation.
Add 50-100 ng of the plasmid in a volume of 25 mL to the cells and mix by gently tapping.
Incubate the vial(s) on ice for 30 min.
Heat shock the cells by incubating the vial(s) for exactly 45 s in a 42 °C water bath and then remove the vial(s) from the 42 °C water bath and quickly place on ice for 5 minutes.
Add 500 mL of pre-warmed SOC medium to the vial(s) and then incubate the vial(s) at 37 °C for 1 h.
Plate the transformation reaction onto LB plates containing ampicillin (100 mg/mL) for plasmid selection. Invert the plates and incubate at 37 °C overnight.
Collect 1 colony from transformed plate and inoculate into 25 mL of autoclaved TB medium (supplemented with 100 mg/mL ampicillin) in a 250 mL Erlenmeyer culture flask. Incubate overnight at 37 °C while shaking at 260 rpm.
Use ~5-10 mL of culture from Step 2 to inoculate 1 L of fresh TB medium containing 100 mg/mL ampicillin and grow in a 2 L Erlenmeyer culture flask at 37 °C until OD600 = 0.8-1.0.
Cool the resulting culture to 25 °C and add IPTG to yield a final concentration of 1 mM.
After 12-16 h of induction with IPTG at 15 °C and stirring at 260 rpm, collect the cells by centrifuging the culture at 6,000 rpm for 60 mins.
Store the cell pallet in -80 °C until further use.
Purification of EP300-KIX87:
Thaw frozen cells and suspend the cells in pre-chilled buffer A. 10 mL of Pierce universal nuclease and a tablet of protease inhibitor cocktail was also added to the suspended cell. Lyse the cells by emulsifex homogenizer at 5000-10000 psi with three rounds of cell lysis (in ice).
Transfer the lysate to a centrifuge tube and centrifuge at 35,000 rpm for 60 min at 4 °C before loading the resultant supernatant onto a 10 ml gravity flow column of containing amylose resin pre-equilibrated with buffer A.
Wash the resin with more than 10 resin-bed volumes using buffer B and then elute the protein with 50 ml of buffer C.
Dilute the eluted protein sample with 800 mL of Triple distilled water (TDW).
Equilibrate an anion exchange chromatography column (Q-Sepharose, 40 ml) with Buffer D using an NGC Liquid Chromatography System.
Load the diluted protein sample from Step 4 onto the pre-equilibrated anion exchange column, wash thoroughly using 120 mL of buffer D and elute using a 0 to 100% linear gradient of buffer E.
Eluted protein fractions were run on SDS PAGE to check the purity. The pure fractions were pooled together and concentrated using an Amicon Ultra-15 Centrifugal Filter (15 ml sample volume, 30 kDa cutoff). Sample concentration was checked using A280 (extinction coefficient: 79300) on a nanodrop.
Sample aliquots were stored at -80 °C until further use.
Samples were buffer exchanged with Buffer F using PD MiniTrap G-25 columns for biochemical assays.
Recipes
Buffer A
20 mM Tris-HCl (pH 7.5)
50 mM NaCl
1 mM EDTA
1 mM DTT
Buffer B
20 mM Tris-HCl (pH 7.5)
1 M NaCl
1 mM EDTA
1 mM DTT
Buffer C
20 mM Tris-HCl (pH 7.5)
50 mM NaCl
1 mM EDTA
1 mM DTT
10 mM Maltose
Buffer D
50 mM Tris-HCl (pH 7.5)
2 mM DTT
1 mM EDTA
Buffer E
50 mM Tris-HCl (pH 7.5)
1 M NaCl
2 mM DTT
1 mM EDTA
Buffer F
50 mM HEPES (pH 7.5)
50 mM NaCl
1 mM DTT
**EP300-KIX as well CREBBP-KIX domain is very prone to degradation during recombinant overexpression and purification. So, the whole purification was carried out at 4 °C. Adding EDTA improves the stability of protein during purification.
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Bushweller, J, Park, K and Kabra, A(2024). Recombinant expression and purification of human EP300-KIX87 domain from Escherichia coli. Bio-protocol Preprint. DOI: 10.21769/p2617.
Kim, K., Kabra, A., Kim, D., Xue, Y., Huang, Y., Hou, P., Zhou, Y., Miranda, L. J., Park, J., Shi, X., Bender, T. P., Bushweller, J. H. and Park, K.(2022). KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer. Science Advances 8(7). DOI: 10.1126/sciadv.abl4618
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.